QQ客服 官方微博 反馈留言

	Discovery of novel selective inhibitors for EGFR-T790M/L858R
	Bai, Fang; Liu, Hongyan; Tong, Linjiang; Zhou, Wei; Liu, Li; Zhao, Zhenjiang; Liu, Xiaofeng; Jiang, Hualiang; Wang, Xicheng; Xie, Hua
刊名	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
	2012
卷号	22页码:1365-1370
关键词	EGFR T790M/L858R Virtual screening Kinase inhibitors Selective inhibitors Dual-effective inhibitors
ISSN号	0960-894X
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4667185
专题	大连理工大学
作者单位	1.Dalian Univ Technol, Dept Engn Mech, State Key Lab Struct Anal Ind Equipment, Dalian 116023, Peoples R China. 2.Dalian Univ Technol, Fac Chem Environm & Biol Sci & Technol, Dalian 116023, Peoples R China. 3.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China. 4.E China Univ Sci & Technol, Sch Pharm, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.,E China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab Chem Biol, Shanghai 200237, Peoples R China. 5.E China Univ Sci & Technol, Sch Pharm, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.,E China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab Chem Biol, Shanghai 200237, Peoples R China. 6.Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China. 7.Dalian Univ Technol, Dept Engn Mech, State Key Lab Struct Anal Ind Equipment, Dalian 116023, Peoples R China.
推荐引用方式 GB/T 7714	Bai, Fang,Liu, Hongyan,Tong, Linjiang,et al. Discovery of novel selective inhibitors for EGFR-T790M/L858R[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,2012,22:1365-1370.
APA	Bai, Fang.,Liu, Hongyan.,Tong, Linjiang.,Zhou, Wei.,Liu, Li.,...&Li, Honglin.(2012).Discovery of novel selective inhibitors for EGFR-T790M/L858R.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,22,1365-1370.
MLA	Bai, Fang,et al."Discovery of novel selective inhibitors for EGFR-T790M/L858R".BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 22(2012):1365-1370.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。